These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15838340)

  • 1. Plasma endothelin-1 in hemodialysis treatment - the influence of hypertension.
    Stefanidis I; Wurth P; Mertens PR; Ikonomov V; Philippidis G; Golphinopoulos S; Makropoulos V; Liakopoulos V; Mann H; Heintz B
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S43-8. PubMed ID: 15838340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1 plasma levels in hemodialysis treatment--the influence of type 2 diabetes.
    Liakopoulos V; Wurth P; Mertens PR; Eleftheriadis T; Kourti P; Voliotis G; Heintz B; Koukoulis GN; Stefanidis I
    Ren Fail; 2005; 27(5):515-22. PubMed ID: 16152988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of recombinant human erythropoietin therapy on plasma endothelin-1 levels during hemodialysis.
    Stefanidis I; Mertens PR; Wurth P; Bach R; Makropoulos W; Mann H; Heintz B
    Int J Artif Organs; 2001 Jun; 24(6):367-73. PubMed ID: 11482502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a hemodialysis session on plasma levels of endothelin-1 in hypertensive and normotensive subjects with end-stage renal failure.
    Surdacki A; Sułowicz W; Wieczorek-Surdacka E; Herman ZS
    Nephron; 1999 Jan; 81(1):31-6. PubMed ID: 9884416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
    Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
    Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased endothelin: nitric oxide ratio is associated with erythropoietin-induced hypertension in hemodialysis patients.
    Shimada N; Saka S; Sekizuka K; Tanaka A; Takahashi Y; Nakamura T; Ebihara I; Koide H
    Ren Fail; 2003 Jul; 25(4):569-78. PubMed ID: 12911161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of volume overload in dialysis-refractory hypertension.
    Fishbane S; Natke E; Maesaka JK
    Am J Kidney Dis; 1996 Aug; 28(2):257-61. PubMed ID: 8768921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma endothelin levels in hypertension and chronic renal failure.
    Shichiri M; Hirata Y; Ando K; Emori T; Ohta K; Kimoto S; Ogura M; Inoue A; Marumo F
    Hypertension; 1990 May; 15(5):493-6. PubMed ID: 2185151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role for endothelin-1 in the hemodynamic changes during hemodialysis?
    El-Shafey EM; El-Nagar GF; Selim MF; El-Sorogy HA; Sabry AA
    Clin Exp Nephrol; 2008 Oct; 12(5):370-375. PubMed ID: 18568290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-II and endothelin-1 levels in children with renoprival hypertension.
    Seguias L; Zilleruelo G; Strauss J; Abitbol C; Montane B
    Pediatr Nephrol; 2001 Jun; 16(6):493-6. PubMed ID: 11420913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arterial hypertension in chronic kidney failure: a volume-dependent pathology or a disease due to malnutrition?].
    Iannetti E; Carpinteri G; Trovato GM
    G Ital Cardiol; 1999 Mar; 29(3):284-90. PubMed ID: 10231674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on the relationship between plasma level of ET-1 and cGRP and blood pressure in hemodialysis patients].
    Zhou Q; Sun M; Li X
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):335-7. PubMed ID: 9868091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin and atrial natriuretic peptide in non-insulin-dependent diabetic versus nondiabetic patients on chronic hemodialysis.
    Schleiffer T; Nagel D; Franz H; Falk M; Valentiner I; Wildburg G; Stark M; Brass H
    Ren Fail; 1994 Nov; 16(6):747-58. PubMed ID: 7899586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced venous responsiveness to endothelin-1 but not noradrenaline in hypertensive chronic renal failure.
    Hand MF; Haynes WG; Webb DJ
    Nephrol Dial Transplant; 2001 Feb; 16(2):295-301. PubMed ID: 11158403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increased adrenomedullin levels in hypertensive patients on maintenance hemodialysis].
    Cases A; Esforzado N; Vera M; Lario S; López-Pedret J; Jiménez W; Rivera-Fillat F
    Nefrologia; 2000; 20(5):424-30. PubMed ID: 11100663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin.
    Raj DS; Vincent B; Simpson K; Sato E; Jones KL; Welbourne TC; Levi M; Shah V; Blandon P; Zager P; Robbins RA
    Kidney Int; 2002 Feb; 61(2):697-704. PubMed ID: 11849413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vascular endothelin system is not overactive in normotensive hemodialysis patients.
    Büssemaker E; Passauer J; Reimann D; Schulze B; Reichel W; Gross P
    Kidney Int; 2002 Sep; 62(3):940-8. PubMed ID: 12164876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efffect of plasminogen activator inhibitor-1 and endothelin-1 on the atherosclerosis in the maintenance hemodialysis patients].
    Ouyang L; Peng Y; Wu G; Xu X; He Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 May; 38(5):458-67. PubMed ID: 23719522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inappropriately elevated endothelin-1 plays a role in the pathogenesis of intradialytic hypertension.
    Teng J; Tian J; Lv WL; Zhang XY; Zou JZ; Fang Y; Yu J; Shen B; Liu ZH; Ding XQ
    Hemodial Int; 2015 Apr; 19(2):279-86. PubMed ID: 25345870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma adrenomedullin levels in hemodialysis patients with sustained hypotension.
    Cases A; Esforzado N; Lario S; Vera M; Lopez-Pedret J; Rivera-Fillat F; Jimenez W
    Kidney Int; 2000 Feb; 57(2):664-70. PubMed ID: 10652045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.